REGENERON PHARMACEUTICALS, INC. (REGN) Shareholders’ equity 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) shareholders’ equity at each fiscal year-end, per SEC filings.
$31.3BFY2025 · since FY2016: $4.4B → $31.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.3B | +6.5% |
| FY2024 | $29.4B | +13.0% |
| FY2023 | $26.0B | +14.6% |
| FY2022 | $22.7B | +20.8% |
| FY2021 | $18.8B | +70.2% |
| FY2020 | $11.0B | -0.6% |
| FY2019 | $11.1B | +26.6% |
| FY2018 | $8.8B | +42.5% |
| FY2017 | $6.1B | +38.1% |
| FY2016 | $4.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice